These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10618802)

  • 1. [The risk of suffering a cardiovascular disease in the making of decisions. From evidence to the clinic].
    Villar Alvarez F; Maiques Galán A; Franch Taix M; Banegas Banegas JR; Vilaseca Canals J
    Med Clin (Barc); 1999; 112 Suppl 1():67-73. PubMed ID: 10618802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond hypertension toward guidelines for cardiovascular risk reduction.
    Volpe M; Alderman MH; Furberg CD; Jackson R; Kostis JB; Laragh JH; Psaty BM; Ruilope LM
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1068-74. PubMed ID: 15533736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calibrating the SCORE cardiovascular risk chart for use in Spain].
    Sans S; Fitzgerald AP; Royo D; Conroy R; Graham I
    Rev Esp Cardiol; 2007 May; 60(5):476-85. PubMed ID: 17535758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
    Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
    Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?].
    Fretheim A; Bjørndal A; Oxman AD; Dyrdal A; Golding M; Ose L; Reikvam A; Teisberg P
    Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2277-81. PubMed ID: 12448268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
    Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
    Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future directions of cardiovascular risk prediction.
    Smith SC
    Am J Cardiol; 2006 Jan; 97(2A):28A-32A. PubMed ID: 16442934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines for the elaboration of programs for the primary prevention of cardiovascular diseases. The Working Group for Primary Cardiovascular Prevention].
    Banegas Banegas JR; Díez García MA; Sánchez RG; Gómez Esmorís L; Jiménez García-Pascual R; Juane Sánchez R; Juncadella García E; Martín Zurro A; Muñiz García J; Pérez Andrés C
    Rev Sanid Hig Publica (Madr); 1993; 67(1):5-22. PubMed ID: 7725051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
    Kostis JB; Jackson G; Rosen R; Barrett-Connor E; Billups K; Burnett AL; Carson C; Cheitlin M; Debusk R; Fonseca V; Ganz P; Goldstein I; Guay A; Hatzichristou D; Hollander JE; Hutter A; Katz S; Kloner RA; Mittleman M; Montorsi F; Montorsi P; Nehra A; Sadovsky R; Shabsigh R
    Am J Cardiol; 2005 Jul; 96(2):313-21. PubMed ID: 16018863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients.
    Gavish D; Leibovitz E; Elly I; Shargorodsky M; Zimlichman R
    Isr Med Assoc J; 2002 Sep; 4(9):694-7. PubMed ID: 12440233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk functions and the primary prevention of cardiovascular disease].
    Grau M; Marrugat J
    Rev Esp Cardiol; 2008 Apr; 61(4):404-16. PubMed ID: 18405521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk assessment for informed decision making. Validity of prediction tools].
    Lenz M; Mühlhauser I
    Med Klin (Munich); 2004 Nov; 99(11):651-61. PubMed ID: 15583875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the SCORE and Wilson-Grundy methods for the assessment of cardiovascular risk in community pharmacies.
    Amariles P; Machuca M; Faus MJ; Baena MI; Martinez-Martinez F; Jimenez-Martin J
    J Clin Pharm Ther; 2008 Oct; 33(5):475-81. PubMed ID: 18834361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of using different methods to assess cardiovascular risk in primary care.
    Fornasini M; Brotons C; Sellarès J; Martinez M; Galán ML; Sáenz I; da Pena JM
    Fam Pract; 2006 Feb; 23(1):28-33. PubMed ID: 16243952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.